A new method of constructing CD20/CD22 bispecfic antibody fusion proteins with improved direct lymphoma cytotoxicity compared to rituximab
Year: 2006
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: C. Chang, M. Losman, M. Loo, Z. Qu, E. A. Rossi, D. M. Goldenberg
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3011058137
